Video
Author(s):
After discussing earlier-line use of CAR T-cell therapy in patients with multiple myeloma, the panel considers key takeaways and future evolutions in the treatment landscape.
Linvoseltamab Generates Efficacy Similar to That Seen With Teclistamab in R/R Myeloma
Oncology Experts Preview Top Abstracts From the 2024 ASCO Annual Meeting
Teclistamab Triplet Shows Manageable Safety, Early Efficacy in Transplant-Ineligible Myeloma
Wagner on the Investigation of Nab-Sirolimus in Advanced Malignant PEComa
Updated Analysis From MajesTEC-1 Confirms CRS Reduction With Prophylactic Tocilizumab in Relapsed/Refractory Myeloma
Exploring the Nuances of Postoperative Considerations in Pancreatic Cancer
ARV-766 Demonstrates Clinical Activity in AR LBD–Mutated Metastatic CRPC
MammaPrint High 2 Indication Could Be Predictive Biomarker for Immunotherapy in HR+/HER2– Early Breast Cancer
Dostarlimab With Carboplatin/Paclitaxel Shows Survival Benefits in dMMR/MSI-H Endometrial Cancer